APO RESEARCH · REPORT
HEPES
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
Product & engineering
Understand the product.
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
Selected research
Industry Growth & Trends
Global HEPES Industry Growth and Trends Forecast to 2032
Market perspective
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
North America is the largest market with about 56% market share. Europe is follower, accounting for about 27% market share.
The key players are Avantor, Thermo Fisher, Merck, Lonza, Cytiva, Promega Corporation, MP Biomedicals, Spectrum Laboratory, Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Bio-Techne, BioSpectra, Corning, FUJIFILM Irvine Scientific, Inc., Dojindo Laboratories, XZL Bio-Technology, Suzhou Yacoo Science, Haihang Chemical, Yunbang Bio-pharmaceutical etc. Top 3 companies occupied about 29% market share.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global HEPES market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The HEPES market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HEPES market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HEPES.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global HEPES market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
HEPES Market by Company
Avantor
Thermo Fisher
Merck
Lonza
Cytiva
Promega Corporation
MP Biomedicals
Spectrum Laboratory
Biological Industries
Cayman Chemical
SERVA Electrophoresis GmbH
Bio-Techne
BioSpectra
Corning
FUJIFILM Irvine Scientific, Inc.
Dojindo Laboratories
XZL Bio-Technology
Suzhou Yacoo Science
Haihang Chemical
Yunbang Bio-pharmaceutical
HEPES Segment by Type
HEPES Powder
HEPES Solution
HEPES Segment by Application
Cell Culture
Protein Extraction
Others
HEPES Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HEPES market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HEPES and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HEPES.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HEPES manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of HEPES in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- HEPES Powder
- HEPES Solution
Applications
- Cell Culture
- Protein Extraction
- Others
Companies covered
- Avantor
- Thermo Fisher
- Merck
- Lonza
- Cytiva
- Promega Corporation
- MP Biomedicals
- Spectrum Laboratory
- Biological Industries
- Cayman Chemical
- SERVA Electrophoresis GmbH
- Bio-Techne
- BioSpectra
- Corning
- FUJIFILM Irvine Scientific, Inc.
- Dojindo Laboratories
- XZL Bio-Technology
- Suzhou Yacoo Science
- Haihang Chemical
- Yunbang Bio-pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global HEPES Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global HEPES Sales Estimates and Forecasts (2021-2032)
- 1.3 HEPES Market by Type
- 1.3.1 HEPES Powder
- 1.3.2 HEPES Solution
- 1.4 Global HEPES Market Size by Type
- 1.4.1 Global HEPES Market Size Overview by Type (2021-2032)
- 1.4.2 Global HEPES Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global HEPES Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America HEPES Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe HEPES Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific HEPES Sales Breakdown by Type (2021-2026)
- 1.5.4 South America HEPES Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa HEPES Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 HEPES Industry Trends
- 2.2 HEPES Industry Drivers
- 2.3 HEPES Industry Opportunities and Challenges
- 2.4 HEPES Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by HEPES Revenue (2021-2026)
- 3.2 Global Top Players by HEPES Sales (2021-2026)
- 3.3 Global Top Players by HEPES Price (2021-2026)
- 3.4 Global HEPES Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global HEPES Major Company Production Sites & Headquarters
- 3.6 Global HEPES Company, Product Type & Application
- 3.7 Global HEPES Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global HEPES Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 HEPES Players Market Share by Revenue in 2025
- 3.8.3 2025 HEPES Tier 1, Tier 2, and Tier 3
4 HEPES Regional Status and Outlook
- 4.1 Global HEPES Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global HEPES Historic Market Size by Region
- 4.2.1 Global HEPES Sales in Volume by Region (2021-2026)
- 4.2.2 Global HEPES Sales in Value by Region (2021-2026)
- 4.2.3 Global HEPES Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global HEPES Forecasted Market Size by Region
- 4.3.1 Global HEPES Sales in Volume by Region (2027-2032)
- 4.3.2 Global HEPES Sales in Value by Region (2027-2032)
- 4.3.3 Global HEPES Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HEPES by Application
- 5.1 HEPES Market by Application
- 5.1.1 Cell Culture
- 5.1.2 Protein Extraction
- 5.1.3 Others
- 5.2 Global HEPES Market Size by Application
- 5.2.1 Global HEPES Market Size Overview by Application (2021-2032)
- 5.2.2 Global HEPES Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global HEPES Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America HEPES Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe HEPES Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific HEPES Sales Breakdown by Application (2021-2026)
- 5.3.4 South America HEPES Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa HEPES Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Avantor
- 6.1.1 Avantor Company Information
- 6.1.2 Avantor Business Overview
- 6.1.3 Avantor HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Avantor HEPES Product Portfolio
- 6.1.5 Avantor Recent Developments
- 6.2 Thermo Fisher
- 6.2.1 Thermo Fisher Company Information
- 6.2.2 Thermo Fisher Business Overview
- 6.2.3 Thermo Fisher HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher HEPES Product Portfolio
- 6.2.5 Thermo Fisher Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck HEPES Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Lonza HEPES Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 Cytiva
- 6.5.1 Cytiva Company Information
- 6.5.2 Cytiva Business Overview
- 6.5.3 Cytiva HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Cytiva HEPES Product Portfolio
- 6.5.5 Cytiva Recent Developments
- 6.6 Promega Corporation
- 6.6.1 Promega Corporation Company Information
- 6.6.2 Promega Corporation Business Overview
- 6.6.3 Promega Corporation HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Promega Corporation HEPES Product Portfolio
- 6.6.5 Promega Corporation Recent Developments
- 6.7 MP Biomedicals
- 6.7.1 MP Biomedicals Company Information
- 6.7.2 MP Biomedicals Business Overview
- 6.7.3 MP Biomedicals HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 MP Biomedicals HEPES Product Portfolio
- 6.7.5 MP Biomedicals Recent Developments
- 6.8 Spectrum Laboratory
- 6.8.1 Spectrum Laboratory Company Information
- 6.8.2 Spectrum Laboratory Business Overview
- 6.8.3 Spectrum Laboratory HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Spectrum Laboratory HEPES Product Portfolio
- 6.8.5 Spectrum Laboratory Recent Developments
- 6.9 Biological Industries
- 6.9.1 Biological Industries Company Information
- 6.9.2 Biological Industries Business Overview
- 6.9.3 Biological Industries HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Biological Industries HEPES Product Portfolio
- 6.9.5 Biological Industries Recent Developments
- 6.10 Cayman Chemical
- 6.10.1 Cayman Chemical Company Information
- 6.10.2 Cayman Chemical Business Overview
- 6.10.3 Cayman Chemical HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Cayman Chemical HEPES Product Portfolio
- 6.10.5 Cayman Chemical Recent Developments
- 6.11 SERVA Electrophoresis GmbH
- 6.11.1 SERVA Electrophoresis GmbH Company Information
- 6.11.2 SERVA Electrophoresis GmbH Business Overview
- 6.11.3 SERVA Electrophoresis GmbH HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 SERVA Electrophoresis GmbH HEPES Product Portfolio
- 6.11.5 SERVA Electrophoresis GmbH Recent Developments
- 6.12 Bio-Techne
- 6.12.1 Bio-Techne Company Information
- 6.12.2 Bio-Techne Business Overview
- 6.12.3 Bio-Techne HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Bio-Techne HEPES Product Portfolio
- 6.12.5 Bio-Techne Recent Developments
- 6.13 BioSpectra
- 6.13.1 BioSpectra Company Information
- 6.13.2 BioSpectra Business Overview
- 6.13.3 BioSpectra HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 BioSpectra HEPES Product Portfolio
- 6.13.5 BioSpectra Recent Developments
- 6.14 Corning
- 6.14.1 Corning Company Information
- 6.14.2 Corning Business Overview
- 6.14.3 Corning HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Corning HEPES Product Portfolio
- 6.14.5 Corning Recent Developments
- 6.15 FUJIFILM Irvine Scientific, Inc.
- 6.15.1 FUJIFILM Irvine Scientific, Inc. Company Information
- 6.15.2 FUJIFILM Irvine Scientific, Inc. Business Overview
- 6.15.3 FUJIFILM Irvine Scientific, Inc. HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 FUJIFILM Irvine Scientific, Inc. HEPES Product Portfolio
- 6.15.5 FUJIFILM Irvine Scientific, Inc. Recent Developments
- 6.16 Dojindo Laboratories
- 6.16.1 Dojindo Laboratories Company Information
- 6.16.2 Dojindo Laboratories Business Overview
- 6.16.3 Dojindo Laboratories HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Dojindo Laboratories HEPES Product Portfolio
- 6.16.5 Dojindo Laboratories Recent Developments
- 6.17 XZL Bio-Technology
- 6.17.1 XZL Bio-Technology Company Information
- 6.17.2 XZL Bio-Technology Business Overview
- 6.17.3 XZL Bio-Technology HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 XZL Bio-Technology HEPES Product Portfolio
- 6.17.5 XZL Bio-Technology Recent Developments
- 6.18 Suzhou Yacoo Science
- 6.18.1 Suzhou Yacoo Science Company Information
- 6.18.2 Suzhou Yacoo Science Business Overview
- 6.18.3 Suzhou Yacoo Science HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Suzhou Yacoo Science HEPES Product Portfolio
- 6.18.5 Suzhou Yacoo Science Recent Developments
- 6.19 Haihang Chemical
- 6.19.1 Haihang Chemical Company Information
- 6.19.2 Haihang Chemical Business Overview
- 6.19.3 Haihang Chemical HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Haihang Chemical HEPES Product Portfolio
- 6.19.5 Haihang Chemical Recent Developments
- 6.20 Yunbang Bio-pharmaceutical
- 6.20.1 Yunbang Bio-pharmaceutical Company Information
- 6.20.2 Yunbang Bio-pharmaceutical Business Overview
- 6.20.3 Yunbang Bio-pharmaceutical HEPES Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Yunbang Bio-pharmaceutical HEPES Product Portfolio
- 6.20.5 Yunbang Bio-pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America HEPES Sales by Country
- 7.1.1 North America HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America HEPES Sales by Country (2021-2026)
- 7.1.3 North America HEPES Sales Forecast by Country (2027-2032)
- 7.2 North America HEPES Market Size by Country
- 7.2.1 North America HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America HEPES Market Size by Country (2021-2026)
- 7.2.3 North America HEPES Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe HEPES Sales by Country
- 8.1.1 Europe HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe HEPES Sales by Country (2021-2026)
- 8.1.3 Europe HEPES Sales Forecast by Country (2027-2032)
- 8.2 Europe HEPES Market Size by Country
- 8.2.1 Europe HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe HEPES Market Size by Country (2021-2026)
- 8.2.3 Europe HEPES Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific HEPES Sales by Country
- 9.1.1 Asia-Pacific HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific HEPES Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific HEPES Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific HEPES Market Size by Country
- 9.2.1 Asia-Pacific HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific HEPES Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific HEPES Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America HEPES Sales by Country
- 10.1.1 South America HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America HEPES Sales by Country (2021-2026)
- 10.1.3 South America HEPES Sales Forecast by Country (2027-2032)
- 10.2 South America HEPES Market Size by Country
- 10.2.1 South America HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America HEPES Market Size by Country (2021-2026)
- 10.2.3 South America HEPES Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa HEPES Sales by Country
- 11.1.1 Middle East and Africa HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa HEPES Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa HEPES Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa HEPES Market Size by Country
- 11.2.1 Middle East and Africa HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa HEPES Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa HEPES Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 HEPES Value Chain Analysis
- 12.1.1 HEPES Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 HEPES Production Mode & Process
- 12.2 HEPES Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 HEPES Distributors
- 12.2.3 HEPES Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst